Lilly and Breast Cancer Advocacy Organizations Collaborate to Drive Awareness of the Complexities of Early Breast Cancer and the Risk of Recurrence
More than 290,650 women and 2,710 men are expected to be diagnosed with breast cancer in the
"Too often, the risk of breast cancer coming back or progressing to metastatic disease is not part of the care team discussion as people navigate diagnosis, treatment, and care. We believe patients benefit from open conversations about breast cancer recurrence," said Jean Sachs, CEO,
This initiative provides educational materials and other resources specifically developed for people with HR+, HER2- EBC and their care partners to better understand the complexity of the disease, including the risk of recurrence. The campaign features a digital fact sheet, patient conversation guide, and infographic, all of which explain the clinical characteristics associated with an increased risk of breast cancer recurrence and provide tools in planning treatment in partnership with a care team. Learn more about the campaign's educational resources here.
"When people are diagnosed with early breast cancer, the initial focus is understandably on selecting and undergoing treatment that will prevent or delay cancer recurrence. However, the risk of developing recurrence may be difficult to comprehend and patients can benefit from additional resources to help understand or augment the information provided by their doctors," said
About Early Breast Cancer
Early breast cancer (EBC) is cancer that has not spread beyond the breast or underarm lymph nodes. The most common type of breast cancer is HR+, HER2-. Most EBC is treatable and does not return. However, there are many factors that may influence whether the breast cancer returns.
About Breastcancer.org
Breastcancer.org is a leading patient-focused resource for breast health and breast cancer education and support. Their mission is to engage and empower people with research, expert information, and a dynamic peer support community to help them make the best decisions for their lives. The nonprofit organization, founded in 2000 by Chief Medical Officer
About For the Breast of Us
For the Breast of Us is the first online inclusive community for women of color affected by breast cancer. Our mission is to empower women of color affected by breast cancer to make the rest of their lives the best of their lives through education, advocacy, and community. Visit breastofus.com for more information.
About Living Beyond Breast Cancer
About
About Lilly Oncology
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly's commitment to people with cancer, please visit www.LillyOncology.com.
About Eli
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at lilly.com and lilly.com/newsroom. P-LLY
PP-AL-US-3051 02/2022 ©
1
Refer to: Tracy Henrikson; tracy.henrikson@lilly.com; 609-454-7116 (Media)
SOURCE